Clene Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
Clene Inc. (CLNN) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of $314.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-03-17
- Clene Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2025 was $314.00K, a 52.43% increase from fiscal 2024.
- Clene Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2024 was $206.00K.
- Clene Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2023 was -$266.00K, a 497.01% decline from fiscal 2022.
- Clene Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2022 was $67.00K, a 89.28% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month |
|---|---|
| 2025-12-31 | $314.00K 10-K · filed 2026-03-17 |
| 2024-12-31 | $206.00K 10-K · filed 2026-03-17 |
| 2023-12-31 | -$266.00K 10-K · filed 2025-03-24 |
| 2022-12-31 | $67.00K 10-K · filed 2024-03-13 |
| 2021-12-31 | $625.00K 10-K · filed 2023-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |